Latest News
Accessing HIV treatments during COVID-19
This updated communication informs PLHIV that Australia still has ample supplies of all HIV medications. In order to avoid going out, PLHIV can now have their HIV treatments posted to them at home by asking their doctor to forward scripts directly to the pharmacy. Information regarding ViiV and Gilead expanding compassionate access of HIV medication for PLHIV stuck in Australia is provided.
Treatment Outreach Network 2020 meeting held online during COVID-19 restrictions
NAPWHA’s Treatment Officer Network held their annual formal meeting via video conferencing during this time of COVID-19 restrictions with informational sessions presented by Dr Liz Crock, Vikas Parwani, Dr Darren Russell, and Associate Professor Edwina Wright.
Take a brief survey about how COVID-19 has impacted you to help us better provide support services to people living with HIV
NAPWHA is undertaking a brief survey of People Living with HIV in Australia so that we are better able to provide support and services in the response to COVID-19.
Nurse Practitioners included as authorised prescribers for HIV, hepatitis B and hepatitis C medicines
From 1 April 2020, Nurse Practitioners (NPs) experienced in the care and management of people living with HIV, hepatitis B and hepatitis C are eligible to prescribe Pharmaceutical Benefit Scheme (PBS) funded medicines for treatment of these blood borne viruses.
COVID-19 health promotion resources recommended by PATSIN
The NAPWHA-auspiced Positive Aboriginal Torres Strait Islander Network (PATSIN) have recommended the below COVID-19 resources for Aboriginal and Torres Strait Islander communities, which have been featured on this webpage and compiled from various organisations.
AIDSwatch2020: “U=U: The impact on Australia”
NAPWHA’s Charlie Tredway was asked by Prevention Access Campaign to set an early morning alarm to join their panel at AIDSwatch 2020, focusing on the impact of U=U on Australia, Denton Callender’s presentation at CROI and what works about our HIV response.
